$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which is better, tucatinib/tucatinib or lapatinib?
2026-02-01 22:25:32
Check Details
What is the difference in price comparison of generic drugs of Alpelisib?
2026-02-01 22:25:32
Check Details
Understanding of Avatrombopag Maleate Tablets in the Real World: Clinical Choices under the Price Reduction of Original Drugs and the Rise of Generic Drugs
2026-02-01 22:25:32
Check Details
Efficacy and cases of ivonib (Tosuvo) in the treatment of patients with cholangiocarcinoma
2026-02-01 22:25:32
Check Details
Is Mitotane the most sensitive drug in cancer cell therapy?
2026-02-01 22:25:32
Check Details
Is pemetinib (dalbertam) the last treatment option for advanced patients?
2026-02-01 22:25:32
Check Details
Is erdafitinib (Bocco) considered safe and tolerable after three years of long-term use with normal liver function?
2026-02-01 22:25:32
Check Details
Analysis of the core efficacy and mechanism of Erlotinib (Loret) and its value in the treatment of lung cancer
2026-02-01 22:25:32
Check Details
Analysis of whether tofacitinib (Shangjie) is an analgesic and why it can improve pain symptoms
2026-02-01 22:25:32
Check Details
How often should the drug be discontinued during long-term treatment with cycloserine, which is more in line with safety regulations?
2026-02-01 22:25:32
Check Details
The current price range of one box of linezolid in the market and the cost difference between different channels
2026-02-01 22:25:32
Check Details
Analysis of why ribociclib (Kaillon) is evaluated as having significant effects and its long-term clinical treatment advantages
2026-02-01 22:25:32
Check Details
1
2
...
2404
2405
2406
2407
2408
2409
2410
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
2
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
3
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
4
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
5
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
6
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
7
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
8
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
9
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
10
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
11
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
12
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment